Search
Feed aggregator
Immutep Aces Phase IIb in First-Line Head and Neck Cancer, Eyes Regulatory Path Ahead
Immutep Aces Phase IIb in First-Line Head and Neck Cancer, Eyes Regulatory Path Ahead 7/12/2024
Senate Unanimously Passes Bill to Reduce Big Pharma Patent Thickets, Increase Competition
Senate Unanimously Passes Bill to Reduce Big Pharma Patent Thickets, Increase Competition 7/12/2024
AbbVie’s Humira Continues to Lose Market Share as Biosimilars Gain Ground: Report
AbbVie’s Humira Continues to Lose Market Share as Biosimilars Gain Ground: Report 7/12/2024
Akebia Ends Deal With CSL Vifor, Unveils Hefty Price Tag for CKD Anemia Drug Vafseo
Akebia Ends Deal With CSL Vifor, Unveils Hefty Price Tag for CKD Anemia Drug Vafseo 7/12/2024
PBMs and Big Pharma Play Blame Game for Inflated Prescription Drug Prices
PBMs and Big Pharma Play Blame Game for Inflated Prescription Drug Prices 7/12/2024
Biopharma Layoff Tracker 2024: Spark, Novartis, Indivior and More Cut Staff
Biopharma Layoff Tracker 2024: Spark, Novartis, Indivior and More Cut Staff 7/12/2024
FDA Decision Tracker: Novo’s Once-Weekly Insulin Icodec Rejected
FDA Decision Tracker: Novo’s Once-Weekly Insulin Icodec Rejected 7/12/2024
EMA Finds No Link Between GLP-1 Drugs and Suicidal Thoughts, Self-Harm
EMA Finds No Link Between GLP-1 Drugs and Suicidal Thoughts, Self-Harm 4/12/2024
EC Approves Illumina’s Plan to Divest Cancer Diagnostics Maker Grail
EC Approves Illumina’s Plan to Divest Cancer Diagnostics Maker Grail 4/12/2024
AACR, Cancer Treatment and the Promise of Antibody-Drug Conjugates
AACR, Cancer Treatment and the Promise of Antibody-Drug Conjugates 4/12/2024
Enlivex’s Stock Plummets 50% on Phase II Sepsis Results for Cell Therapy
Enlivex’s Stock Plummets 50% on Phase II Sepsis Results for Cell Therapy 4/12/2024
Lilly Suffers Legal Loss in Tirzepatide Case Against Compounding Pharmacy
Lilly Suffers Legal Loss in Tirzepatide Case Against Compounding Pharmacy 4/12/2024
AstraZeneca Expands Fasenra’s Label to Younger Children with Severe Asthma
AstraZeneca Expands Fasenra’s Label to Younger Children with Severe Asthma 4/12/2024
Fujifilm Pumps $1.2B into CDMO Capacity in North Carolina, Eyes 680 New Jobs by 2031
Fujifilm Pumps $1.2B into CDMO Capacity in North Carolina, Eyes 680 New Jobs by 2031 4/12/2024
Vaccines, Next-Gen Approaches Target the Toughest Cancers: AACR
Vaccines, Next-Gen Approaches Target the Toughest Cancers: AACR 4/12/2024
CryoEM: Evolution and Best Practices
CryoEM: Evolution and Best Practices 4/12/2024
Pfizer Moves Forward With Obesity Pill, Plans Dose Optimization Studies This Year
Pfizer Moves Forward With Obesity Pill, Plans Dose Optimization Studies This Year 7/11/2024
Ipsen Inks Potential $1B First-in-Class ADC Deal With Foreseen
Ipsen Inks Potential $1B First-in-Class ADC Deal With Foreseen 7/11/2024
Kazia Offers Secondary OS Data to Build FDA Case for Glioblastoma Drug
Kazia Offers Secondary OS Data to Build FDA Case for Glioblastoma Drug 7/11/2024
FDA Rejects Novo’s Once-Weekly Insulin Injection, Cites Manufacturing Process
FDA Rejects Novo’s Once-Weekly Insulin Injection, Cites Manufacturing Process 7/11/2024
World Pharma News
- Novel drug application shows improved survival for patients with relapsed and refractory acute myeloid leukemia
- Study shows ancient viruses fuel modern-day cancers
- Darolutamide meets primary endpoint in Phase III ARANOTE trial
- Pfizer advances development of once-daily formulation of oral GLP-1 receptor agonist danuglipron
- New AI approach optimizes antibody drugs